speb/financial-data huggingface dataset:
GENM.TO income_statement (annual, 2023-12-31) — +Operating Expense: 19219978.00
GENM.TO income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
GENM.TO balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 0.00
GENM.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -292710.00
GENM.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 1900177.00
GENM.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 188640082.00
GENM.TO income_statement (annual, 2023-12-31) — Basic EPS: -0.09
GENM.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 18766791.00
GENM.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2546451.00
GENM.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 80429321.00
GENM.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 16457963.00
GENM.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 16457963.00
GENM.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 13871860.00
GENM.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -116235.00
GENM.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -16064453.00
GENM.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3083384.00
GENM.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 81603.00
GENM.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 1607098.00
GENM.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -1394683.00
GENM.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -2308828.00
GENM.TO balance_sheet (annual, 2023-12-31) — Common Stock: 80429321.00
GENM.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: -29389053.00
GENM.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 13863349.00
GENM.TO balance_sheet (annual, 2023-12-31) — Current Assets: 16719415.00
GENM.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 2459192.00
GENM.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2459192.00
GENM.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 4792818.00
GENM.TO cash_flow (annual, 2023-12-31) — Depreciation: 1500741.00
GENM.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1500741.00
GENM.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1500741.00
GENM.TO balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 44731750.00
GENM.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 188640082.00
GENM.TO income_statement (annual, 2023-12-31) — Diluted EPS: -0.09
GENM.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -17763257.00
GENM.TO income_statement (annual, 2023-12-31) — EBIT: -17382009.00
GENM.TO income_statement (annual, 2023-12-31) — EBITDA: -15881268.00
GENM.TO income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -95321.00
GENM.TO cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 95321.00
GENM.TO cash_flow (annual, 2023-12-31) — End Cash Position: 16457963.00
GENM.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 13871860.00
GENM.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -16064453.00
GENM.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -2830000.00
GENM.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -2830000.00
GENM.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 2830000.00
GENM.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -1332006.00
GENM.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -2602649.00
GENM.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 4355572.00
GENM.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 1426932.00
GENM.TO income_statement (annual, 2023-12-31) — Interest Expense: 381248.00
GENM.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 381248.00
GENM.TO income_statement (annual, 2023-12-31) — Interest Income: 435296.00
GENM.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 435296.00
GENM.TO balance_sheet (annual, 2023-12-31) — Invested Capital: -29389053.00
GENM.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -116235.00
GENM.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 2104679.00
GENM.TO balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 2104679.00
GENM.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 13863349.00
GENM.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 87259.00
GENM.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 87259.00
GENM.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -507489.00
GENM.TO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 2104679.00
GENM.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 68494.00
GENM.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 13863349.00
GENM.TO income_statement (annual, 2023-12-31) — Net Income: -17763257.00
GENM.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -17763257.00
GENM.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -17763257.00
GENM.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -17763257.00
GENM.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -17763257.00
GENM.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -17763257.00
GENM.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -17763257.00
GENM.TO income_statement (annual, 2023-12-31) — Net Interest Income: 54048.00
GENM.TO cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: 630000.00
GENM.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -507489.00
GENM.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -507489.00
GENM.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 54048.00
GENM.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -746235.00
GENM.TO balance_sheet (annual, 2023-12-31) — Net PPE: 1134222.00
GENM.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 630000.00
GENM.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -29389053.00
GENM.TO balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 226229.00
GENM.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -17379262.00
GENM.TO income_statement (annual, 2023-12-31) — Normalized Income: -19261251.00
GENM.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -16064453.00
GENM.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -2734679.00
GENM.TO income_statement (annual, 2023-12-31) — Operating Income: -19219978.00
GENM.TO income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
GENM.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 236053408.00
GENM.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 387120.00
GENM.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2602649.00
GENM.TO balance_sheet (annual, 2023-12-31) — Other Equity Interest: 7372816.00
GENM.TO income_statement (annual, 2023-12-31) — Other Gand A: 3162014.00
GENM.TO income_statement (annual, 2023-12-31) — Other Income Expense: 1402673.00
GENM.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1345008.00
GENM.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 38229.00
GENM.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -1345008.00
GENM.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 14864406.00
GENM.TO balance_sheet (annual, 2023-12-31) — Other Properties: 1358438.00
GENM.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 19010.00
GENM.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1946506.00
GENM.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 136562.00
GENM.TO income_statement (annual, 2023-12-31) — Pretax Income: -17763257.00
GENM.TO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 516000.00
GENM.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
GENM.TO balance_sheet (annual, 2023-12-31) — Receivables: 124890.00
GENM.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1500741.00
GENM.TO income_statement (annual, 2023-12-31) — Rent And Landing Fees: 111318.00
GENM.TO income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 111318.00
GENM.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -507489.00
GENM.TO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 14864406.00
GENM.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -114588541.00
GENM.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 1082240.00
GENM.TO cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 630000.00
GENM.TO cash_flow (annual, 2023-12-31) — Sale Of PPE: 630000.00
GENM.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 4355572.00
GENM.TO balance_sheet (annual, 2023-12-31) — Share Issued: 236053408.00
GENM.TO income_statement (annual, 2023-12-31) — Special Income Charges: 2830000.00
GENM.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1082240.00
GENM.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: -29389053.00
GENM.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -29389053.00
GENM.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
GENM.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
GENM.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 105880.00
GENM.TO balance_sheet (annual, 2023-12-31) — Total Assets: 20222774.00
GENM.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: -29389053.00
GENM.TO balance_sheet (annual, 2023-12-31) — Total Debt: 2546451.00
GENM.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -29389053.00
GENM.TO income_statement (annual, 2023-12-31) — Total Expenses: 19219978.00
GENM.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 49611827.00
GENM.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3503359.00
GENM.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 44819009.00
GENM.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 1497994.00
GENM.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 1497994.00
GENM.TO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 1345008.00
GENM.TO balance_sheet (annual, 2023-12-31) — Working Capital: 11926597.00
GENM.TO cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
GENM.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 236619943.00
GENM.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.03
GENM.TO cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Investing Activities: 0.00
GENM.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 236619943.00
GENM.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.03
GENM.TO income_statement (quarterly, 2024-09-30) — Interest Income: 106052.00
GENM.TO income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 106052.00
GENM.TO cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: 0.00
GENM.TO balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 807254.00
GENM.TO cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 0.00
GENM.TO balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 45456.00
GENM.TO cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: -69536.00
GENM.TO income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 69536.00
GENM.TO cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
GENM.TO cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
GENM.TO income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
GENM.TO income_statement (annual, 2024-12-31) — +Operating Expense: 11566480.00
GENM.TO income_statement (quarterly, 2024-12-31) — +Operating Expense: 1432593.00
GENM.TO income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
GENM.TO income_statement (quarterly, 2024-12-31) — +Total Revenue: 0.00
GENM.TO balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 215799.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Accrued Interest Receivable: 215799.00
GENM.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -387393.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -387393.00
GENM.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 146229.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
GENM.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 236443964.00
GENM.TO income_statement (annual, 2024-12-31) — Basic EPS: -0.09
GENM.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 16457963.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 7041503.00
GENM.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -23517.00
GENM.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1610042.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1610042.00
GENM.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 80733587.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Capital Stock: 80733587.00
GENM.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 5525287.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 5525287.00
GENM.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5525287.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5525287.00
GENM.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -729508.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -188546.00
GENM.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -23517.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
GENM.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -10179651.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -1327670.00
GENM.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -529393.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 99785.00
GENM.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -84728.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: -112627.00
GENM.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -129967.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Change In Receivables: -165301.00
GENM.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -744088.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -178143.00
GENM.TO cash_flow (annual, 2024-12-31) — Changes In Cash: -10932676.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Changes In Cash: -1516216.00
GENM.TO balance_sheet (annual, 2024-12-31) — Common Stock: 80733587.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Common Stock: 80733587.00
GENM.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: -49781052.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -49781052.00
GENM.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
GENM.TO balance_sheet (annual, 2024-12-31) — Current Assets: 6001435.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Current Assets: 6001435.00
GENM.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1539217.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 1539217.00
GENM.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1539217.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 1539217.00
GENM.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 2956330.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 2956330.00
GENM.TO cash_flow (annual, 2024-12-31) — Depreciation: 378709.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Depreciation: 41665.00
GENM.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 378709.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 41665.00
GENM.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 378709.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 41665.00
GENM.TO balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 55103411.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 55103411.00
GENM.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 236443964.00
GENM.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.09
GENM.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -21620120.00
GENM.TO income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -3783878.00
GENM.TO income_statement (annual, 2024-12-31) — EBIT: -21332163.00
GENM.TO income_statement (quarterly, 2024-12-31) — EBIT: -3722150.00
GENM.TO income_statement (annual, 2024-12-31) — EBITDA: -20953454.00
GENM.TO income_statement (quarterly, 2024-12-31) — EBITDA: -3680485.00
GENM.TO income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -700304.00
GENM.TO income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 261301.00
GENM.TO cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 700304.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Earnings Losses From Equity Investments: -261301.00
GENM.TO cash_flow (annual, 2024-12-31) — End Cash Position: 5525287.00
GENM.TO cash_flow (quarterly, 2024-12-31) — End Cash Position: 5525287.00
GENM.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -729508.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -188546.00
GENM.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -10203168.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -1327670.00
GENM.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
GENM.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
GENM.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -10376255.00
GENM.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -2766625.00
GENM.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -2602649.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -2602649.00
GENM.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 3040238.00
GENM.TO income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 410255.00
GENM.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 1212868.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1212868.00
GENM.TO income_statement (annual, 2024-12-31) — Interest Expense: 287957.00
GENM.TO income_statement (quarterly, 2024-12-31) — Interest Expense: 61728.00
GENM.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 287957.00
GENM.TO income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 61728.00
GENM.TO income_statement (annual, 2024-12-31) — Interest Income: 670409.00
GENM.TO income_statement (quarterly, 2024-12-31) — Interest Income: 170311.00
GENM.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 670409.00
GENM.TO income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 170311.00
GENM.TO balance_sheet (annual, 2024-12-31) — Invested Capital: -49781052.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Invested Capital: -49781052.00
GENM.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -23517.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 0.00
GENM.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 1404375.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 1404375.00
GENM.TO balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 1404375.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 1404375.00
GENM.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
GENM.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 70825.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 70825.00
GENM.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 70825.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 70825.00
GENM.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -729508.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -188546.00
GENM.TO balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 1404375.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 1404375.00
GENM.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 92011.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 92011.00
GENM.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
GENM.TO income_statement (annual, 2024-12-31) — Net Income: -21620120.00
GENM.TO income_statement (quarterly, 2024-12-31) — Net Income: -3783878.00
GENM.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -21620120.00
GENM.TO income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -3783878.00
GENM.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -21620120.00
GENM.TO income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -3783878.00
GENM.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -21620120.00
GENM.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3783878.00
GENM.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -21620120.00
GENM.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3783878.00
GENM.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -21620120.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -3783878.00
GENM.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -21620120.00
GENM.TO income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -3783878.00
GENM.TO income_statement (annual, 2024-12-31) — Net Interest Income: 382452.00
GENM.TO income_statement (quarterly, 2024-12-31) — Net Interest Income: 108583.00
GENM.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -729508.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -188546.00
GENM.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -729508.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -188546.00
GENM.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 382452.00
GENM.TO income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 108583.00
GENM.TO balance_sheet (annual, 2024-12-31) — Net PPE: 825475.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Net PPE: 825475.00
GENM.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -23517.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
GENM.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -49781052.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -49781052.00
GENM.TO balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 80000.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 80000.00
GENM.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -10830546.00
GENM.TO income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -913860.00
GENM.TO income_statement (annual, 2024-12-31) — Normalized Income: -11497212.00
GENM.TO income_statement (quarterly, 2024-12-31) — Normalized Income: -1017253.00
GENM.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -10179651.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -1327670.00
GENM.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 700304.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -261301.00
GENM.TO income_statement (annual, 2024-12-31) — Operating Income: -11566480.00
GENM.TO income_statement (quarterly, 2024-12-31) — Operating Income: -1432593.00
GENM.TO income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
GENM.TO income_statement (quarterly, 2024-12-31) — Operating Revenue: 0.00
GENM.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 236992106.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 236992106.00
GENM.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -2602649.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -2602649.00
GENM.TO balance_sheet (annual, 2024-12-31) — Other Equity Interest: 8296671.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 8296671.00
GENM.TO income_statement (annual, 2024-12-31) — Other Gand A: 1723188.00
GENM.TO income_statement (quarterly, 2024-12-31) — Other Gand A: 253017.00
GENM.TO income_statement (annual, 2024-12-31) — Other Income Expense: -10436092.00
GENM.TO income_statement (quarterly, 2024-12-31) — Other Income Expense: -2459868.00
GENM.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -640467.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -45456.00
GENM.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 38229.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 38229.00
GENM.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 387120.00
GENM.TO income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 45456.00
GENM.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 8526242.00
GENM.TO income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 1022338.00
GENM.TO balance_sheet (annual, 2024-12-31) — Other Properties: 1120857.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 1120857.00
GENM.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 1446.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Other Receivables: 1446.00
GENM.TO income_statement (annual, 2024-12-31) — Other Special Charges: -253347.00
GENM.TO income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
GENM.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1417113.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 1417113.00
GENM.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 221290.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 221290.00
GENM.TO income_statement (annual, 2024-12-31) — Pretax Income: -21620120.00
GENM.TO income_statement (quarterly, 2024-12-31) — Pretax Income: -3783878.00
GENM.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
GENM.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -23517.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
GENM.TO balance_sheet (annual, 2024-12-31) — Receivables: 254858.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Receivables: 254858.00
GENM.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 378709.00
GENM.TO income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 41665.00
GENM.TO income_statement (annual, 2024-12-31) — Rent And Landing Fees: 88929.00
GENM.TO income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: 21717.00
GENM.TO income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 88929.00
GENM.TO income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: 21717.00
GENM.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -729508.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -188546.00
GENM.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -136208661.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -136208661.00
GENM.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 1228121.00
GENM.TO income_statement (quarterly, 2024-12-31) — Salaries And Wages: 135521.00
GENM.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
GENM.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 3040238.00
GENM.TO income_statement (quarterly, 2024-12-31) — Selling General And Administration: 410255.00
GENM.TO balance_sheet (annual, 2024-12-31) — Share Issued: 236992106.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Share Issued: 236992106.00
GENM.TO income_statement (annual, 2024-12-31) — Special Income Charges: 253347.00
GENM.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
GENM.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1228121.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 135521.00
GENM.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: -49781052.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -49781052.00
GENM.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: -49781052.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -49781052.00
GENM.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
GENM.TO income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
GENM.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
GENM.TO income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
GENM.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 37613.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 37613.00
GENM.TO balance_sheet (annual, 2024-12-31) — Total Assets: 8349514.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Total Assets: 8349514.00
GENM.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: -49781052.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -49781052.00
GENM.TO balance_sheet (annual, 2024-12-31) — Total Debt: 1610042.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Total Debt: 1610042.00
GENM.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -49781052.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -49781052.00
GENM.TO income_statement (annual, 2024-12-31) — Total Expenses: 11566480.00
GENM.TO income_statement (quarterly, 2024-12-31) — Total Expenses: 1432593.00
GENM.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 58130566.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 58130566.00
GENM.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 2348079.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 2348079.00
GENM.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 55174236.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 55174236.00
GENM.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -10122908.00
GENM.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: -2766625.00
GENM.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -10122908.00
GENM.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -2766625.00
GENM.TO cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 10371661.00
GENM.TO cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 2763922.00
GENM.TO balance_sheet (annual, 2024-12-31) — Working Capital: 3045105.00
GENM.TO balance_sheet (quarterly, 2024-12-31) — Working Capital: 3045105.00
GENM.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 1741920.00
GENM.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 232479.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -411064.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
GENM.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 236992106.00
GENM.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.02
GENM.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 5525287.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1409967.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 80733587.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3507538.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3507538.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -200074.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1817675.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -265394.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 91611.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -57431.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -231214.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2017749.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 80733587.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -55505600.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 3949505.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1341807.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1341807.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2493526.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 46194.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 46194.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 46194.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 58251539.00
GENM.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 236992106.00
GENM.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.02
GENM.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -5849024.00
GENM.TO income_statement (quarterly, 2025-03-31) — EBIT: -5793620.00
GENM.TO income_statement (quarterly, 2025-03-31) — EBITDA: -5747426.00
GENM.TO income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -943765.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 943765.00
GENM.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 3507538.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -200074.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1817675.00
GENM.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -3148620.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2602649.00
GENM.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 489087.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1190345.00
GENM.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 55404.00
GENM.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 55404.00
GENM.TO income_statement (quarterly, 2025-03-31) — Interest Income: 40685.00
GENM.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 40685.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: -55505600.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 460610.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 460610.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 68160.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 68160.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -200074.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 460610.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 92011.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
GENM.TO income_statement (quarterly, 2025-03-31) — Net Income: -5849024.00
GENM.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -5849024.00
GENM.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -5849024.00
GENM.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -5849024.00
GENM.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -5849024.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -5849024.00
GENM.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -5849024.00
GENM.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -14719.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -200074.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -200074.00
GENM.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -14719.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 779281.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -55505600.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 80000.00
GENM.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2598806.00
GENM.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -2700404.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1817675.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 943765.00
GENM.TO income_statement (quarterly, 2025-03-31) — Operating Income: -1741920.00
GENM.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 236992106.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2602649.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 8421147.00
GENM.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 342966.00
GENM.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -4092385.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 38229.00
GENM.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1252833.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 1098334.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1447.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1151719.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 129679.00
GENM.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -5849024.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 312288.00
GENM.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 46194.00
GENM.TO income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 21645.00
GENM.TO income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 21645.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -200074.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -142057685.00
GENM.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 124476.00
GENM.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 489087.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 236992106.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 124476.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -55505600.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -55505600.00
GENM.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GENM.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 78362.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 5307625.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -55505600.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 1409967.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -55505600.00
GENM.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 1741920.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 60813225.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1358120.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 58319699.00
GENM.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -3148620.00
GENM.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -3148620.00
GENM.TO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 3148128.00
GENM.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 1455979.00
GENM.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 2470759.00
GENM.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 255182.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -434735.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
GENM.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 237018304.00
GENM.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.02
GENM.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 3507538.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1204761.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 89188827.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 13037317.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 13037317.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 10548921.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1019142.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 710118.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -30260.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -22597.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 657261.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 9529779.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 89188827.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -49304881.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 10754128.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 13532140.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1204761.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1204761.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3066598.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 40392.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 40392.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 40392.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 61563188.00
GENM.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 237018304.00
GENM.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.02
GENM.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -5312684.00
GENM.TO income_statement (quarterly, 2025-06-30) — EBIT: -5264862.00
GENM.TO income_statement (quarterly, 2025-06-30) — EBITDA: -5224470.00
GENM.TO income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 475036.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -475036.00
GENM.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 13037317.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 10548921.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1019142.00
GENM.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -3310276.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2602649.00
GENM.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1104102.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1173625.00
GENM.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 47822.00
GENM.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 47822.00
GENM.TO income_statement (quarterly, 2025-06-30) — Interest Income: 41137.00
GENM.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 41137.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: -49304881.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 935646.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 935646.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 10754128.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 0.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -205207.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 935646.00
GENM.TO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 92011.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 10754128.00
GENM.TO income_statement (quarterly, 2025-06-30) — Net Income: -5312684.00
GENM.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -5312684.00
GENM.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -5312684.00
GENM.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -5312684.00
GENM.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -5312684.00
GENM.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -5312684.00